| Dr Susan Frayer, MD | |
|
306 E Maumee St Ste 303, Angola, IN 46703-2044 | |
| (260) 667-5685 | |
| (260) 667-5564 |
| Full Name | Dr Susan Frayer |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 26 Years |
| Location | 306 E Maumee St Ste 303, Angola, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598757684 | NPI | - | NPPES |
| 104529434 | Medicaid | MI | |
| 200256660 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 01050884A (Indiana) | Secondary |
| 208000000X | Pediatrics | 01050884A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Marion General Hospital | Marion, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Marion General Hospital | 9133023625 | 98 |
News Archive
Researchers at Albert Einstein College of Medicine of Yeshiva University have developed an experimental vaccine that appears to protect against an increasingly common and particularly deadly form of pneumococcal pneumonia. Details of the new vaccine, which was tested in an animal model, are reported in a paper published today in the Journal of Infectious Diseases.
In Pennsylvania, the payments suggested that "[p]harmaceutical company money continued flowing to University of Pittsburgh Medical Center doctors last year, despite a restrictive two-year-old policy designed to limit drug company influence, and reflecting the struggle academic medical centers face in distancing doctors from drug companies," the Pittsburgh Business Times reports
The frequency of vena cava filter use to prevent migration of blood clots to the lungs in patients with acute venous thromboembolism appears to vary widely and be associated with which hospital provides the patient care, according to a study of California hospitals published Online First by JAMA Internal Medicine, a JAMA Network publication.
TESARO, Inc. announced today that the first clinical trial of its proprietary Anaplastic Lymphoma Kinase (ALK) inhibitor, TSR-011, has commenced with the dosing of the first patient at the Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen).
A recent study has found that changes in microbial communities within the reproductive tract of pregnant women were strongly linked to premature birth.
› Verified 3 days ago
| Entity Name | Cameron Memorial Community Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770521478 PECOS PAC ID: 9234020835 Enrollment ID: O20040323001008 |
News Archive
Researchers at Albert Einstein College of Medicine of Yeshiva University have developed an experimental vaccine that appears to protect against an increasingly common and particularly deadly form of pneumococcal pneumonia. Details of the new vaccine, which was tested in an animal model, are reported in a paper published today in the Journal of Infectious Diseases.
In Pennsylvania, the payments suggested that "[p]harmaceutical company money continued flowing to University of Pittsburgh Medical Center doctors last year, despite a restrictive two-year-old policy designed to limit drug company influence, and reflecting the struggle academic medical centers face in distancing doctors from drug companies," the Pittsburgh Business Times reports
The frequency of vena cava filter use to prevent migration of blood clots to the lungs in patients with acute venous thromboembolism appears to vary widely and be associated with which hospital provides the patient care, according to a study of California hospitals published Online First by JAMA Internal Medicine, a JAMA Network publication.
TESARO, Inc. announced today that the first clinical trial of its proprietary Anaplastic Lymphoma Kinase (ALK) inhibitor, TSR-011, has commenced with the dosing of the first patient at the Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen).
A recent study has found that changes in microbial communities within the reproductive tract of pregnant women were strongly linked to premature birth.
› Verified 3 days ago
| Entity Name | Marion General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528099041 PECOS PAC ID: 9133023625 Enrollment ID: O20040524001483 |
News Archive
Researchers at Albert Einstein College of Medicine of Yeshiva University have developed an experimental vaccine that appears to protect against an increasingly common and particularly deadly form of pneumococcal pneumonia. Details of the new vaccine, which was tested in an animal model, are reported in a paper published today in the Journal of Infectious Diseases.
In Pennsylvania, the payments suggested that "[p]harmaceutical company money continued flowing to University of Pittsburgh Medical Center doctors last year, despite a restrictive two-year-old policy designed to limit drug company influence, and reflecting the struggle academic medical centers face in distancing doctors from drug companies," the Pittsburgh Business Times reports
The frequency of vena cava filter use to prevent migration of blood clots to the lungs in patients with acute venous thromboembolism appears to vary widely and be associated with which hospital provides the patient care, according to a study of California hospitals published Online First by JAMA Internal Medicine, a JAMA Network publication.
TESARO, Inc. announced today that the first clinical trial of its proprietary Anaplastic Lymphoma Kinase (ALK) inhibitor, TSR-011, has commenced with the dosing of the first patient at the Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen).
A recent study has found that changes in microbial communities within the reproductive tract of pregnant women were strongly linked to premature birth.
› Verified 3 days ago
| Entity Name | Cameron Memorial Community Hospital Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1386683316 PECOS PAC ID: 9234020835 Enrollment ID: O20060622000002 |
News Archive
Researchers at Albert Einstein College of Medicine of Yeshiva University have developed an experimental vaccine that appears to protect against an increasingly common and particularly deadly form of pneumococcal pneumonia. Details of the new vaccine, which was tested in an animal model, are reported in a paper published today in the Journal of Infectious Diseases.
In Pennsylvania, the payments suggested that "[p]harmaceutical company money continued flowing to University of Pittsburgh Medical Center doctors last year, despite a restrictive two-year-old policy designed to limit drug company influence, and reflecting the struggle academic medical centers face in distancing doctors from drug companies," the Pittsburgh Business Times reports
The frequency of vena cava filter use to prevent migration of blood clots to the lungs in patients with acute venous thromboembolism appears to vary widely and be associated with which hospital provides the patient care, according to a study of California hospitals published Online First by JAMA Internal Medicine, a JAMA Network publication.
TESARO, Inc. announced today that the first clinical trial of its proprietary Anaplastic Lymphoma Kinase (ALK) inhibitor, TSR-011, has commenced with the dosing of the first patient at the Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen).
A recent study has found that changes in microbial communities within the reproductive tract of pregnant women were strongly linked to premature birth.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Susan Frayer, MD 416 E Maumee St, Angola, IN 46703-2015 Ph: (260) 667-5131 | Dr Susan Frayer, MD 306 E Maumee St Ste 303, Angola, IN 46703-2044 Ph: (260) 667-5685 |
News Archive
Researchers at Albert Einstein College of Medicine of Yeshiva University have developed an experimental vaccine that appears to protect against an increasingly common and particularly deadly form of pneumococcal pneumonia. Details of the new vaccine, which was tested in an animal model, are reported in a paper published today in the Journal of Infectious Diseases.
In Pennsylvania, the payments suggested that "[p]harmaceutical company money continued flowing to University of Pittsburgh Medical Center doctors last year, despite a restrictive two-year-old policy designed to limit drug company influence, and reflecting the struggle academic medical centers face in distancing doctors from drug companies," the Pittsburgh Business Times reports
The frequency of vena cava filter use to prevent migration of blood clots to the lungs in patients with acute venous thromboembolism appears to vary widely and be associated with which hospital provides the patient care, according to a study of California hospitals published Online First by JAMA Internal Medicine, a JAMA Network publication.
TESARO, Inc. announced today that the first clinical trial of its proprietary Anaplastic Lymphoma Kinase (ALK) inhibitor, TSR-011, has commenced with the dosing of the first patient at the Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen).
A recent study has found that changes in microbial communities within the reproductive tract of pregnant women were strongly linked to premature birth.
› Verified 3 days ago